Stella Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Stella Pharma has a total shareholder equity of ¥2.4B and total debt of ¥933.0M, which brings its debt-to-equity ratio to 39.3%. Its total assets and total liabilities are ¥3.8B and ¥1.4B respectively.
Key information
39.3%
Debt to equity ratio
JP¥933.00m
Debt
Interest coverage ratio | n/a |
Cash | JP¥2.35b |
Equity | JP¥2.38b |
Total liabilities | JP¥1.44b |
Total assets | JP¥3.82b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4888's short term assets (¥3.6B) exceed its short term liabilities (¥455.0M).
Long Term Liabilities: 4888's short term assets (¥3.6B) exceed its long term liabilities (¥989.0M).
Debt to Equity History and Analysis
Debt Level: 4888 has more cash than its total debt.
Reducing Debt: 4888's debt to equity ratio has reduced from 96.9% to 39.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4888 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4888 has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 0.3% each year.